JP2002508738A - クラミジア・ニューモニアに起因する心臓疾患の処置方法 - Google Patents
クラミジア・ニューモニアに起因する心臓疾患の処置方法Info
- Publication number
- JP2002508738A JP2002508738A JP51909098A JP51909098A JP2002508738A JP 2002508738 A JP2002508738 A JP 2002508738A JP 51909098 A JP51909098 A JP 51909098A JP 51909098 A JP51909098 A JP 51909098A JP 2002508738 A JP2002508738 A JP 2002508738A
- Authority
- JP
- Japan
- Prior art keywords
- patients
- azithromycin
- heart disease
- chlamydia
- disease caused
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Electrotherapy Devices (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 有効量のマクロライド抗生物質を、所望により一つ以上の薬理的に許容さ れる担体または賦形剤とともに、被検者に投与することからなる、アテローマ動 脈硬化症の克服方法。 2. 第一の有効量のアジスロマイシン投与の約1か月後に、第二の有効量のア ジスロマイシンを投与する、請求項1に記載の方法。 3. 一つまたはそれ以上のさらなる有効量のアジスロマイシンを、1か月また はそれ以上の間隔で追加する、請求項2に記載の方法。 4. アテローム動脈硬化症の克服に用いられる薬剤の製造への、アジスロマイ シンまたはその誘導体の使用。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2869396P | 1996-10-18 | 1996-10-18 | |
GBGB9621771.6A GB9621771D0 (en) | 1996-10-18 | 1996-10-18 | Method of treatment of heart disease |
US9621771.6 | 1996-10-18 | ||
US60/028,693 | 1996-10-18 | ||
PCT/GB1997/002862 WO1998017280A1 (en) | 1996-10-18 | 1997-10-17 | Method of treatment of heart disease caused by chlamydia pneumoniae |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2002508738A true JP2002508738A (ja) | 2002-03-19 |
JP3580829B2 JP3580829B2 (ja) | 2004-10-27 |
Family
ID=26310252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51909098A Expired - Lifetime JP3580829B2 (ja) | 1996-10-18 | 1997-10-17 | クラミジア・ニューモニアに起因する心臓疾患の処置方法 |
Country Status (13)
Country | Link |
---|---|
US (1) | US6281199B1 (ja) |
EP (1) | EP0952835B1 (ja) |
JP (1) | JP3580829B2 (ja) |
AT (1) | ATE262910T1 (ja) |
AU (1) | AU736983B2 (ja) |
CA (1) | CA2269054C (ja) |
DE (1) | DE69728420T2 (ja) |
DK (1) | DK0952835T3 (ja) |
ES (1) | ES2218665T3 (ja) |
GB (1) | GB9621771D0 (ja) |
NZ (1) | NZ335825A (ja) |
PT (1) | PT952835E (ja) |
WO (1) | WO1998017280A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004094446A1 (ja) * | 2003-04-24 | 2004-11-04 | Japan Science And Technology Agency | 14員環マクロライド化合物を利用した、血管平滑筋の増殖に起因する疾患治療剤 |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6710033B1 (en) | 1996-08-14 | 2004-03-23 | Vanderbilt University | Methods and treatment of multiple sclerosis |
US6890526B2 (en) | 1997-05-06 | 2005-05-10 | Vanderbilt University | Methods and reagents for the treatment of multiple sclerosis |
FR2771008B1 (fr) * | 1997-11-17 | 2000-04-28 | Hoechst Marion Roussel Inc | Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose |
US6861411B1 (en) | 1997-12-02 | 2005-03-01 | Pfizer, Inc. | Method of treating eye infections with azithromycin |
FR2791436B1 (fr) * | 1999-03-23 | 2001-06-15 | Inst Nat Sante Rech Med | Methode de determination d'une predisposition a une maladie tromboembolique veineuse et utilisation d'agents actifs sur les chlamydia pour la prevention et/ou le traitement de cette maladie |
US7056893B2 (en) | 1999-03-31 | 2006-06-06 | Insite Vision, Inc. | Topical treatment for prevention of ocular infections |
US6239113B1 (en) | 1999-03-31 | 2001-05-29 | Insite Vision, Incorporated | Topical treatment or prevention of ocular infections |
IL133038A0 (en) * | 1999-11-18 | 2001-03-19 | Savyon Diagnostics Ltd | Novel diagnosis and treatment for atherosclerosis |
KR20010069066A (ko) | 2000-01-12 | 2001-07-23 | 이종원 | 저산소 농도하에서 생존이 가능하도록 하는 동물세포의배양방법 |
US6914051B1 (en) * | 2000-06-28 | 2005-07-05 | David M Allen | Penetrating antibiotic gel for soft tissue diseases |
US7335638B2 (en) * | 2000-07-03 | 2008-02-26 | Maria De Lourdes Higuchi | Prevention and treatment of mycoplasma-associated diseases |
CA2383850C (en) * | 2000-07-03 | 2012-02-07 | Maria De Lourdes Higuchi | Prevention and treatment of mycoplasma-associated diseases |
US7419657B2 (en) * | 2001-08-22 | 2008-09-02 | Cambridge Theranostics Ltd. | Treatment of atherosclerotic disorders |
AU2003265241A1 (en) * | 2002-05-23 | 2003-12-12 | Activbiotics, Inc. | Methods of treating bacterial infections and diseases associated therewith |
US20040077533A1 (en) * | 2002-05-23 | 2004-04-22 | Sayada Chalom B. | Methods and compositions for treating bacterial infections and diseases associated therewith |
US20090149453A1 (en) * | 2002-05-23 | 2009-06-11 | Activbiotics Pharma Llc | Methods and compositions for treating bacterial infections and diseases associated therewith |
WO2004009084A1 (en) * | 2002-07-18 | 2004-01-29 | Pfizer Products Inc. | Methods of treating infection using antibiotics and glycogen phosphorylase inhibitors |
WO2004054513A2 (en) * | 2002-12-12 | 2004-07-01 | Activbiotics, Inc. | Methods and compositions for treating and preventing ear infections |
EP1575567A4 (en) * | 2002-12-12 | 2008-10-08 | Activbiotics Inc | METHOD AND REAGENTS FOR TREATING OR PREVENTING ATHEROSCLEROSIS AND DISEASES ASSOCIATED WITH IT |
US7674832B2 (en) * | 2003-03-28 | 2010-03-09 | Higuchi Maria De Lourdes | Compositions for promoting wound healing and treating psoriasis |
US8822232B2 (en) | 2003-03-28 | 2014-09-02 | Maria De Lourdes Higuchi | Diagnosis, prevention and treatment of disorders characterized by undesirable cell proliferation |
BRPI1004987A2 (pt) | 2010-11-26 | 2013-03-26 | Maria De Lourdes Higuchi | prevenÇço e tratamento de doenÇas associadas as micoplasma |
US7732410B2 (en) * | 2003-03-28 | 2010-06-08 | Higuchi Maria De Lourdes | Compositions for inhibiting atherosclerosis |
US7468428B2 (en) * | 2004-03-17 | 2008-12-23 | App Pharmaceuticals, Llc | Lyophilized azithromycin formulation |
US20060116336A1 (en) * | 2004-03-17 | 2006-06-01 | American Pharmaceutical Partners, Inc. | Lyophilized azithromycin formulation |
AU2013363571A1 (en) * | 2012-12-17 | 2015-07-16 | Cormatrix Cardiovascular, Inc. | Intra-myocardial agent delivery device, system and method |
US11660269B2 (en) * | 2019-03-29 | 2023-05-30 | University Of Kentucky Research Foundation | Liposomal compounds and methods of use thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4427782A (en) | 1981-03-03 | 1984-01-24 | Caldwell Harlan D | Isolation of principal outer membrane protein and antigen of Chlamydia trachomatis |
DE3650571T2 (de) | 1985-01-14 | 1997-02-27 | Chiron Corp | Hauptprotein der Aussenmembran von Chlamydia |
FI883067A (fi) | 1988-06-27 | 1989-12-28 | Labsystems Oy | Foerfarande foer behandling av koronarkaerlsjukdom. |
WO1992022819A1 (en) * | 1991-06-14 | 1992-12-23 | Board Of Regents Of The University Of Washington | Diagnosis and treatment of arterial chlamydial granuloma |
-
1996
- 1996-10-18 GB GBGB9621771.6A patent/GB9621771D0/en active Pending
-
1997
- 1997-10-17 AU AU47126/97A patent/AU736983B2/en not_active Ceased
- 1997-10-17 ES ES97909440T patent/ES2218665T3/es not_active Expired - Lifetime
- 1997-10-17 EP EP97909440A patent/EP0952835B1/en not_active Expired - Lifetime
- 1997-10-17 DE DE69728420T patent/DE69728420T2/de not_active Expired - Lifetime
- 1997-10-17 NZ NZ335825A patent/NZ335825A/xx unknown
- 1997-10-17 WO PCT/GB1997/002862 patent/WO1998017280A1/en active IP Right Grant
- 1997-10-17 DK DK97909440T patent/DK0952835T3/da active
- 1997-10-17 CA CA002269054A patent/CA2269054C/en not_active Expired - Lifetime
- 1997-10-17 JP JP51909098A patent/JP3580829B2/ja not_active Expired - Lifetime
- 1997-10-17 AT AT97909440T patent/ATE262910T1/de not_active IP Right Cessation
- 1997-10-17 PT PT97909440T patent/PT952835E/pt unknown
-
1999
- 1999-04-19 US US09/294,013 patent/US6281199B1/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004094446A1 (ja) * | 2003-04-24 | 2004-11-04 | Japan Science And Technology Agency | 14員環マクロライド化合物を利用した、血管平滑筋の増殖に起因する疾患治療剤 |
Also Published As
Publication number | Publication date |
---|---|
NZ335825A (en) | 2001-01-26 |
PT952835E (pt) | 2004-08-31 |
CA2269054C (en) | 2005-05-03 |
DK0952835T3 (da) | 2004-08-02 |
AU736983B2 (en) | 2001-08-09 |
US6281199B1 (en) | 2001-08-28 |
DE69728420D1 (de) | 2004-05-06 |
CA2269054A1 (en) | 1998-04-30 |
AU4712697A (en) | 1998-05-15 |
DE69728420T2 (de) | 2004-12-30 |
ES2218665T3 (es) | 2004-11-16 |
ATE262910T1 (de) | 2004-04-15 |
GB9621771D0 (en) | 1996-12-11 |
WO1998017280A1 (en) | 1998-04-30 |
EP0952835B1 (en) | 2004-03-31 |
JP3580829B2 (ja) | 2004-10-27 |
EP0952835A1 (en) | 1999-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3580829B2 (ja) | クラミジア・ニューモニアに起因する心臓疾患の処置方法 | |
Winter et al. | Cyclosporin A retention enemas in refractory distal ulcerative colitis and ‘pouchitis’ | |
Mantzaris et al. | A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis. | |
Järnerot et al. | Intensive intravenous treatment of ulcerative colitis | |
Cymbala et al. | The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis | |
Real et al. | Kaposi's sarcoma and the acquired immunodeficiency syndrome: treatment with high and low doses of recombinant leukocyte A interferon. | |
Derkx et al. | Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock | |
Pain et al. | Experimental and clinical study of lactulose in obstructive jaundice | |
DeAbate et al. | The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis | |
Schönwald et al. | Comparison of azithromycin and erythromycin in the treatment of atypical pneumonias | |
Kennedy et al. | Treatment of acute graft-versus-host disease after allogeneic marrow transplantation. Randomized study comparing corticosteroids and cyclosporine | |
Ritz et al. | Severe pneumococcal pneumonia following treatment with infliximab for Crohn's disease | |
Karma et al. | Azithromycin concentrations in sinus fluid and mucosa after oral administration | |
Cantrell et al. | Infective endocarditis in the aging patient | |
Naito et al. | Esophageal candidiasis | |
JPH10505578A (ja) | 全身性炎症および炎症性肝炎の処置のためのピリミジンヌクレオチド前駆体 | |
JPH11500140A (ja) | アムロジピン、アムロジピン塩、もしくはフェロジピンとace阻害薬とを含有する組成物 | |
US4960765A (en) | Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration | |
JP2008514721A (ja) | 治療方法 | |
JP3455633B2 (ja) | 潰瘍性大腸炎の予防又は治療剤 | |
Yadav et al. | Current strategies for the treatment of ulcerative colitis | |
Zalla | Kaposi's Sarcoma An Update | |
Heikkila et al. | The pharmacokinetics of mecillinam and pivmecillinam in pregnant and non‐pregnant women. | |
Ricevuti et al. | Serum, sputum and bronchial concentrations of erythromycin in chronic bronchitis after single and multiple treatments with either propionate-N-acetylcysteinate or stearate erythromycin | |
JP2023502015A (ja) | マルチターゲット型プロテインキナーゼ阻害剤の用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040308 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20040622 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20040721 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070730 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080730 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090730 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100730 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110730 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120730 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130730 Year of fee payment: 9 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |